Bio Green Med Solution (BGMS) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 91.31% |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 17.25% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 37.89% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 37.44% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | -38.56% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 62.15% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 57.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.40% |
| Mar 31, 2026 | 66.66% |
| Dec 31, 2025 | -10.84% |
| Sep 30, 2025 | 21.87% |
| Jun 30, 2025 | 33.86% |
| Mar 31, 2025 | 73.09% |
| Dec 31, 2024 | -32.65% |
| Sep 30, 2024 | 33.57% |
| Jun 30, 2024 | 14.31% |
| Mar 31, 2024 | 5.83% |
| Dec 31, 2023 | -12.60% |
| Sep 30, 2023 | -38.16% |
| Jun 30, 2023 | -35.38% |
| Mar 31, 2023 | -66.42% |
| Dec 31, 2022 | -62.68% |
| Sep 30, 2022 | -39.07% |
| Jun 30, 2022 | -36.14% |
| Mar 31, 2022 | -30.01% |
| Dec 31, 2021 | 97.10% |
| Sep 30, 2021 | -46.61% |